Matthew Kim

  • I attended Washington University School of Medicine in St. Louis and completed an internship and residency in Internal Medicine at the Hospital of the University of Pennsylvania. I completed fellowship training in Endocrinology and Metabolism at Johns Hopkins under the direction of Dr. Paul W. Ladenson, and continued on as a clinical faculty member at that institution before moving to Boston to join the Thyroid Section of Brigham and Women’s Hospital. During my time at Johns Hopkins I garnered extensive experience in the management of patients with thyroid cancer during a transitional period when practice began to evolve to incorporate the use of recombinant TSH in monitoring and treatment protocols, increased utilization of dedicated ultrasonography and FDG-PET scanning to detect persistent disease, and the identification of a range of molecular and genetic markers that play a role in the characterization of different tumors.


     

 

Leave a Reply

  • Upcoming Events

     

    World Congress on Thyroid Cancer 3.5
    Rome, Italy | 2019

    World Congress on Thyroid Cancer 4.0
    July 29 – August 1, 2021
    Boston, Massachusetts

     

  • WCTC3.5 Steering Committee:

     

    Rocco Bellatone, Co-Chair
    Celestino Lombardi, Co-Chair
    Gregory W. Randolph, MD
    Bryan McIver, MD
    Jeremy Freeman, MD
    Ian J. Witterick, MD
    Ashok R. Shaha, MD
    Jatin P. Shah, MD